Clinical Research and Progress in the Treatment of Breast Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 July 2024 | Viewed by 516
Special Issue Editors
Interests: breast cancer; treatment
Special Issue Information
Dear Colleagues,
Clinical research and progress in the treatment of early breast cancer comprise both locoregional treatment and systemic therapy. Locoregional treatment includes the surgery of the breast and the axilla and radiotherapy of the breast or chest wall and regional nodes. Most of the surgical morbidity in the treatment of breast cancer is caused by axilla surgery. Thus, surgical de-escalation strategies investigate reducing axilla surgery, or even disregarding this intervention in patients without a worse locoregional outcome risk. The short-duration radiotherapy of early breast cancer or even omission of radiotherapy in low-risk patients are clinical research issues.
Neoadjuvant therapy in early breast cancer is the standard of care in triple-negative and HER2-positive breast cancer as the adjustment of post-neoadjuvant systemic therapy based on the treatment response to neoadjuvant therapy enables long-term outcome improvements. Multiple translational research projects currently focus on the detection of circulating tumor DNA in early breast cancer indicating a high risk of relapse even though it is still unknown whether early treatment based on the detection of ctDNA may improve outcomes.
The current standard of care and the future developments in locoregional and systemic therapy will be discussed in this Special Issue.
Prof. Dr. Jens Bodo Huober
Dr. Inga Bekes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- early breast cancer
- de-escalation
- locoregional treatment
- axilla surgery
- radiotherapy
- neoadjuvant therapy
- post-neoadjuvant therapy
- ctDNA detection
